The number of diabetic foot lesions and consequently amputations is increasing in the Western Pacific Region (WPR). However, there are no foot care specialists such as podiatrists in WPR and there is much ignorance amongst medical staff as to how to identify and educate those at risk and treat those who develop problems. In order to increase awareness and reduce amputations, we have launched the study (ASIPAC FOOT STUDY) to investigate the characteristics of diabetic patients with foot ulcers in WPR. General patient characteristics were different in all countries. Some countries did not show a higher prevalence of foot ulceration in men. Younger patients with shorter duration of diabetes were more affected in some countries. Neuropathy was diagnosed in most patients, while peripheral arterial disease (PAD) varied between countries. Smoking rate was high in most countries. Many patients came to the hospital late after the onset of the wounds complicated with severe infection. The amputation rate was high in WPR. The characteristics of diabetic foot patients in WPR were much different in some points from those in other regions. Diabetic foot patients with PAD seem to be increasing in this region, while smoking rates are high and revascularization is seldom applied. In order to reduce amputations, it is essential to increase awareness of diabetic foot and tobacco problems, and improve the skills of screening and education of high risk patients and management of foot ulcer through regional practical guideline and professional training program. EDUCATION: 1984 MD, Shinsyu University School of Medicine, Matsumoto, Japan 1992 PhD, Kyoto University Graduate School of Medicine, Kyoto, Japan : 1984-1987 Internal Medicine, Osaka Red Cross Hospital, Osaka, Japan 1992-1993 Staff in Internal Medicine, Kyoto University Hospital, Kyoto, Japan 1993-1997 Staff Vietnam is a developing country. The major medical characteristic is in the same time have to face with infected diseases such as tuberculosis, cholera etc. together with the non-infectious diseases in which diabetes is a typical one. In 1990s of the 20th century, the rate of diabetes is from 0.9 to 2.5%, but now it is 5.7%, especially is 7.2-10% in the cities and industrial zones. These numbers show the fact that even Vietnam is not in the group of countries with highest rate of diabetes, but Vietnam is in the group with rapidest developing rate in the world. Vietnamese patients are usually discovered lately; and hospitalized with serious complications in which the foot one must be named. The characteristic of diabetes foot complication of Vietnamese is the combined injury of serious neural complication (more than 90% of diabetes has neural complication) together with the small blood vessel injury (95%) and gangrene injury which is 90%. Another important characteristic of diabetes foot complication in Vietnam is the infection (more than 90%). Due to these points, the rate of amputating legs of Vietnamese diabetes is quite high -more than 40%. In the future the diabetes foot issue will still be difficult to solve in Vietnam. Perhaps because of Vietnam is a agricultural developing country without the system to discover and early diagnose diabetes in general and foot disease in particular. Obesity is a pandemic medical and social problem that is associated with several adverse health outcomes, including type 2 diabetes, hypertension, dyslipidemia, cardiovascular disease, and cancer, all of which result in increased mortality. A major metabolic manifestation of obesity is systemic insulin resistance. Recently, the concept has emerged that chronic low-grade activation of pro-inflammatory pathways in adipose tissue directly promotes systemic insulin resistance. Adipocytes and macrophages could be a source of several pro-inflammatory cytokines that activate inflammatory pathways in resident and infiltrating cells within adipose tissue in a paracrine or autocrine fashion. However, the molecular mechanisms underlying inflammation of adipose tissue in obesity has not fully clarified. Here, we show that angiopoietin-like protein 2 (Angptl2) was secreted by adipose tissue and that its circulating level was closely related to adiposity, systemic insulin resistance, and inflammation in both mice and humans. Angptl2 activated an inflammatory cascade in endothelial cells via integrin signaling and induced chemotaxis of monocytes/macrophages. Constitutive Angptl2 activation in vivo induced inflammation of the vasculature characterized by abundant attachment of leukocytes to the vessel walls and increased permeability. Angptl2 deletion ameliorated adipose tissue inflammation and systemic insulin resistance in diet-induced obese mice. Conversely, Angptl2 overexpression in adipose tissue caused local inflammation and systemic insulin resistance in non-obese mice. These findings establish Angptl2 as a key adipocyte-derived inflammatory mediator linking obesity to systemic insulin resistance and identify it as a new molecular target that could be used to improve the diagnosis and treatment of obesity and related metabolic diseases. EDUCATION: 1984EDUCATION: -1990 MD In addition to the classical risk factors, aberrant production of adipose tissue-derived factors (adipokines) has recently been proposed as a key pathological link between obesity, diabetes and vascular dysfunction. Among dozens of adipokines characterized so far, adipocyte fatty acid binding (A-FABP, also called aP2) has recently attracted great attention. Mice with the targeted disruption of the A-FABP gene are protected from developing key features of the metabolic syndrome in both genetic and dietary obesity, and are resistant to atherosclerosis in the apoEdeficient background. BMS309403, a selective inhibitor of A-FABP, is effective for the treatment of diabetes as well as atherosclerosis in animal models. In humans, serum levels of A-FABP display a sexual dimorphism and are markedly elevated in obesity. In a 5-year prospective study including 495 nondiabetic Chinese, we found that baseline A-FABP levels predict the development of the metabolic syndrome, independent of adiposity, insulin resistance and other classical risk factors. In another 10-year follow-up study, we have also identified high serum A-FABP as an independent risk factor for type II diabetes. The adverse cardio-metabolic effects of A-FABP are attributed to its pro-inflammatory properties, through activation of C-Jun NH2-terminal kinase (JNK) and induction of endoplasmic reticulum stress. In both endothelial cells and macrophages, A-FABP is essential for free fatty acids-induced activation of key inflammatory pathways, leading to vascular inflammation and endothelial dysfunction. A-FABP might represent a promising biomarker for risk prediction and a drug target for therapeutic intervention of vascular disease associated with obesity and diabetes.
SP1-3 Diabetes Foot in Vietnam
Ta Van Binh National Hospital of Endocrinology, Hanoi, Vietnam Vietnam is a developing country. The major medical characteristic is in the same time have to face with infected diseases such as tuberculosis, cholera etc. together with the non-infectious diseases in which diabetes is a typical one. In 1990s of the 20th century, the rate of diabetes is from 0.9 to 2.5%, but now it is 5.7%, especially is 7.2-10% in the cities and industrial zones. These numbers show the fact that even Vietnam is not in the group of countries with highest rate of diabetes, but Vietnam is in the group with rapidest developing rate in the world. Vietnamese patients are usually discovered lately; and hospitalized with serious complications in which the foot one must be named. The characteristic of diabetes foot complication of Vietnamese is the combined injury of serious neural complication (more than 90% of diabetes has neural complication) together with the small blood vessel injury (95%) and gangrene injury which is 90%. Another important characteristic of diabetes foot complication in Vietnam is the infection (more than 90%). Due to these points, the rate of amputating legs of Vietnamese diabetes is quite high -more than 40%. In the future the diabetes foot issue will still be difficult to solve in Vietnam. Perhaps because of Vietnam is a agricultural developing country without the system to discover and early diagnose diabetes in general and foot disease in particular. EDUCATION: 1982 MD, Hanoi Medical University, Vietnam. 1982 -1985 Internal Medicine, Hanoi Medical University, Bach Mai Hospital 1991 -1992 Medical Trainee, Yamanashi Medical University College, Japan 1999
PhD, Hanoi Medical University, Bach Mai Hospital
SP1-4 Diabetes Foot Care in Indonesia
Sidartawan Soegondo Department of Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia Indonesia has around seven million diabetics among its 240 million people. The major barrier for prevention of diabetic foot problems is lack of trained staff, especially trained nurses that are able to provide proper care to people with diabetes and diabetic foot. Awareness and skills related to diabetes management amongst physicians are still low in Indonesia. Hospitals with diabetic foot clinics were very scarce and programs for diabetic foot prevention do not exist. Since 2008 there are efforts to start improving the capacity for prevention and care of diabetic foot by increasing the capacity of 25 provincial hospitals in managing the diabetic foot and establishing five diabetic foot care centers.
To start this project four trainers were trained in India in order to gain specialised knowledge on diabetic foot problems. After the training they shared their acquired knowledge and skills with other potential trainers. Training modules, guidelines and education materials for patients, doctors and nurses about diabetic foot care were then developed. Upon completion of the training, diabetic foot clinics were set up. Advanced diabetic foot centers were established in Jakarta and Surabaya. Forty, foot care teams (40 internist & 42 nurses) from all provinces in Indonesia have undergone basic foot care training in these two centers. Advanced course focused on enhancing skills in management of severe foot problems such as large ulcer and gangrene are planned. More detailed data will be presented later. Obesity is a pandemic medical and social problem that is associated with several adverse health outcomes, including type 2 diabetes, hypertension, dyslipidemia, cardiovascular disease, and cancer, all of which result in increased mortality. A major metabolic manifestation of obesity is systemic insulin resistance. Recently, the concept has emerged that chronic low-grade activation of pro-inflammatory pathways in adipose tissue directly promotes systemic insulin resistance. Adipocytes and macrophages could be a source of several pro-inflammatory cytokines that activate inflammatory pathways in resident and infiltrating cells within adipose tissue in a paracrine or autocrine fashion. However, the molecular mechanisms underlying inflammation of adipose tissue in obesity has not fully clarified. Here, we show that angiopoietin-like protein 2 (Angptl2) was secreted by adipose tissue and that its circulating level was closely related to adiposity, systemic insulin resistance, and inflammation in both mice and humans. Angptl2 activated an inflammatory cascade in endothelial cells via integrin signaling and induced chemotaxis of monocytes/macrophages. Constitutive Angptl2 activation in vivo induced inflammation of the vasculature characterized by abundant attachment of leukocytes to the vessel walls and increased permeability. Angptl2 deletion ameliorated adipose tissue inflammation and systemic insulin resistance in diet-induced obese mice. Conversely, Angptl2 overexpression in adipose tissue caused local inflammation and systemic insulin resistance in non-obese mice. These findings establish Angptl2 as a key adipocyte-derived inflammatory mediator linking obesity to systemic insulin resistance and identify it as a new molecular target that could be used to improve the diagnosis and treatment of obesity and related metabolic diseases.
SP2-3 Potential Therapeutic Approach of Metabolic Syndrome and Cardiovascular Diseases Targeted at Adiponectin Gene Expression
Lee-Ming Chuang Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
Obesity plays an important causative role in the pathogenesis of insulin resistance and metabolic syndrome. One of the links between obesity and the associated clinical disorders might be due to the dysregulated adipokines. Among them, adiponectin, which possesses antiinflammatory and insulin-sensitizing properties, has been considered of therapeutic potential in the management of the metabolic syndrome, type 2 diabetes, and cardiovascular diseases. In an attempt to identify the gene that might involve regulation of expression of adiponectin, we had mapped a QTL for circulating adiponectin concentration on the chr 15 in the Chinese population. With extensive SNP typing of the genes within this QTL, we found the SNPs of one gene, termed X, were highly associated with adiponectin levels with age-and sex-adjustment. The expression was suppressed during adipogenesis in the 3T3-L1 adipocytes culture system. Silencing X gene resulted in an increase in adiponectin expression at the mRNA and protein levels. The increase in expression was at least partially explained by transcriptional regulation as the promoter activity of the adiponectin gene was upregulated when we silenced X gene. We then employed siRNA injection targeted at X gene in the db/db mice. We found the expression of gene X in the adipose tissue was reduced with an elevation in circulating adiponectin concentration. In parallel, insulin sensitivity as assessed with insulin tolerance test was improved. With this successful proof-of-concept study, we provide a potentially new avenue for raising adiponectin in ameliorating insulin resistance and the related clinical disorders. EDUCATION: 1971 EDUCATION: -1978 MD, Medical College of National Taiwan University, Taiwan 1983 Taiwan -1987 PhD Increased oxidative stress has been regarded as an important mediator of development and progression of diabetes and its vascular complications. Here, we investigated whether antioxidant treatment applying a new protein transduction technology may enable the pancreatic islets and mesangial cells to protect from various forms of oxidative damage. The intracellular activities of the antioxidants were found to increase in line with the amount of protein delivered into the cells. Hydrogen peroxide and cytokine injury, glucolipotoxicity as well as hypoxia in pancreatic islets were found to reduce cell survival in a dose-dependent manner and markedly increase intracellular ROS levels and apoptosis, and the antioxidant treatment decreased intracellular ROS and apoptosis and restored insulin secretion. In addition, the antioxidant treatment also decreased intracellular ROS and the activation of protein kinase C, MAPK, and transcription factors such as NF-kB and AP-1 in mesangial cells. Moreover, the antioxidant treatment protected streptozotocin-treated ICR mice and OLETF rats from developing diabetes and its microvascular complications. A single intraperitoneal injection of the newly developed antioxidants resulted in the delivery to the pancreas, kidney and nerves. Moreover, increased radical scavenging activity in the different organs was induced by multiple injections of them, which enhanced the tolerance of pancreatic beta cells, nerves and kidney to oxidative stress and delayed the development of diabetes and its complications. Our findings indicate that the antioxidant treatment applying a new protein transduction technology offer a new strategy for protecting diabetes and its complication development by relieving oxidative stress. EDUCATION: 1980 -1986 MD, Seoul National University, College of Medicine 1987 -1990 Intern Recent data show that blood glucose (BG) variability is an HbA1c-independent risk factor for diabetic complications. However, the widespread clinical application of continuous glucose monitoring (CGM) is limited by the lack of generally accepted reference values. A multicenter study was conducted to establish preliminary normal reference values for CGM parameters in a sample of healthy Chinese subjects. A total of 434 healthy individuals with normal glucose regulation completed a 3-day period of glucose monitoring using a CGM system. The daily blood glucose varied from 76.9 ± 11.3 to 144.2 ± 23.2 mg/dL. The 24-h mean blood glucose (24-h MBG), and the percentage of time that blood glucose levels >140 mg/dL (PT140) and <70 mg/dL (PT70) within 24 h were 104 ± 10 mg/dL, 4.1 ± 5.8%, and 2.4 ± 5.3%, respectively. As for these parameters, no significant differences were found between men and women. The 95th percentile values were 119 mg/dL (6.6 mmol/L) for 24-h MBG, 17% for PT140, and 12% for PT70, which were recommend as normal ranges for the Chinese population. The characteristics of BG variability in newly diagnosed type 2 diabetic patients were further studied using CGM system. Their mean amplitude of glycemic excursions (MAGE), mean of daily differences (MODD), and the incremental areas above preprandial glucose values (AUCpp) levels were all higher than those of subjects with normal glucose regulation. After treatment with either insulin or oral hypoglycemic administration, significant decreases in MAGE, MODD, and AUCpp were observed. In Japan, under a national law, new health checkup and health care advice system with a particular focus on the metabolic syndrome has been introduced since April 2008. Companies and local governments must measure the waist circumference of people with aged between 40 and 74 years old as part of their annual checkups. Therefore, the word 'METABO' becomes an extremely popular term expressing metabolic syndrome in Japan. In the current definition of the metabolic syndrome by IDF as well as the Japanese one published in 2005, abdominal obesity as defined by waist circumference is the required component. The cut-off points, 85 cm for men and 90 cm for women at the level of the umbilicus decided by the Examination Committee of Criteria for the Metabolic Syndrome in Japan, were based on the original crosssectional data from Japanese subjects, and were the corresponding value for the visceral fat area (VFA) of 100 cm 2 at the level of the umbilicus, rather than a specific value of BMI. However, there is a controversy in the cut-off point for women since it is smaller than that for men in any other countries except Japan. Although waist circumference, relatively direct index of visceral obesity, is clearly associated with the accumulation of metabolic abnormalities, it is still unclear whether waist circumference itself can predict future CVD events more reliably than other obesity indices. Thus, a nationwide survey to optimize the Japanese criteria for the metabolic syndrome by integrating twelve crosssectional and retro-prospective cohort studies has been conducted, and the criteria of the waist circumference or other components for the metabolic syndrome would be revised based on the results drawn from the survey in near future. The harmonization of the criteria for diagnosis of the metabolic syndrome has led to the International Diabetes Federation doing away with the presence of a specific waist measure as a sine qua non for the diagnosis and making this as one of the criteria for the diagnosis of the metabolic syndrome. Concurrently, the NHLBI/AHA definition has also accepted that there may be a need for ethnic and country specific waist measure cut points. At the same time, serious concerns have been raised that removing the sine qua non would dramatically increase the numbers with metabolic syndrome in many countries in Asia especially in the poor and developing countries which would bear the greatest burden of this pandemic. In India, the number of people with metabolic syndrome would increase significantly by almost 60 million people using the harmonized definition. At the same time, the number of people who already have diabetes but are unaware of this is around 50%, especially in rural regions where more than 75% of India lives. The Government spends only 0.9% of its GDP on health and most of this is for acute care communicable diseases. The presentation will detail the prevalence numbers of metabolic syndrome based on both the original criteria and also the prevalence of T2DM in India and show the health and socio-economic burden of this problem and the consequences of the increased numbers with metabolic syndrome following the harmonisation. This is extremely important as we should not blur the borders between expenditure of national medical resources for clinical intervention against public health intervention to stem to the rising tsunami of T2DM and atherosclerotic CVD in India as well as many countries which also have major communicable disease problems to manage and a significant percentage of its population too poor to pay for their own health care. So what is the way forward!
SP3-3
Metabolic Syndrome in Taiwan: An Update
Wayne H-H Sheu Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan
With growing economic booming, prevalence of metabolic syndrome increase rapidly in Taiwan. In a population based study with age greater than 19, the age-standardized prevalence of metabolic syndrome was 15.7% by the modified ATP III criteria, and 16.4% by the Metabolic Syndrome-Asia criteria. The prevalence of obesity and metabolic syndrome significantly increased with age (trend test, P < 0.0001) in men and women. The risk of metabolic syndrome and its components increased significantly with BMI, and showed a marked increase with BMI >24 kg/m 2 . In a cross-sectional survey in a representative sample of 2359 adults aged greater than 40 years who lived in central Taiwan, the prevalence of metabolic syndrome was 35.3 and 43.2% in men aged 40-64 years and 65 years and over, respectively, and 24.19 and 51.82% in women aged 40-64 years and 65 years and over, using modified ATP III criteria. Metabolic syndrome usually associated with high uric acid level and fatty liver disease, mainly in middle aged population. Information from cohort following up study also revealed that several component of metabolic syndrome, in particularly elevated fasting glucose levels predict new onset of diabetes subsequently. Data from healthy check up population indicated that metabolic syndrome plus the presence of postmeal hyperglycemia provide better prediction of future cardiovascular death in a non-diabetes population.
SP3-4
The New Procedure for Prevention of Metabolic Syndrome in All Japan
Chikako Ito Grand Tower Medical Court, Hiroshima, Japan
The government started new measure (the specific health examination and health guidance) from April of 2008. This is a population approach for all Japanese with 40 years old or more of age. Individual companies take the responsibility. Purpose of this health examination is to detect metabolic syndrome (MS) at the early stage. As for a relation between visceral fat area (VFA) and west circumference by many levels of abdomen in Japanese, there are good correlations between VFA and west circumference. And VFA being 100 m 2 calculated 85 cm of west circumference in man and 90 cm in woman on the navel levels. Therefore, cases with circumference being 85 cm or more of in the man and 90 cm or more in the woman, or BMI ‡ 25 are detected. And if there are two or three abnormalities of blood glucose, lipid, and blood pressure, and smoking as an additional risks. Guidance of the lifestyle with positive or motive supported for 3-6 months are provided if necessary. This measure will be become a big helping for prevention of diabetes and of coronary heart diseases in the future. MS has a high relation to development rate of diabetes. In cases with one risk factor, the rate 41.3/1000 PY, 2.5 times higher than non-MS cases. In cases with two risk factors, the rate was 67.6/1000 PY and four times higher, in cases with three risk factors, the rate was 100.8 /1000 PY and six times higher. The rate was increased by increasing number of risk factors. There has been a comprehensive complication of data regarding the epidemiology of metabolic syndrome in Mongolia. Evidence acquisition: we include diabetes mellitus and metabolic syndrome with clinical and public health significance. We identified population based studies that provided in Mongolia prevalence and/or incidence data by searching Pubmed in December 2009 for English language reports, hand-searching reference lists of annual scientific meeting abstract books of the medical university, obtained additional recourse from identified experts in endocrinology and metabolism, and searching epidemiological databases and web sites of relevant organizations. When available, we selected articles with data from 1998 or later. Otherwise, we selected the article with the most recent data. Ultimately, we abstracted data from 18 articles and five reports.
Evidence Synthesis: Life style related disease with Mongolian prevalence estimates as: Diabetes mellitus 8.2%, Impaired Glucose Tolerance 10%, Metabolic syndrome 20.1%, hypertension 28%.
Conclusion:
The current review shows high prevalence of the life style related diseases among Mongolian population. Defining the epidemiology of these conditions will provide dues to risk factors and identify areas to allocate public health and resources. EDUCATION: 1991 Bachelor of Medicine (General Practitioner), National 
